- RecruitingPHASE3
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
This study compares a new treatment, TAR-210, with standard chemotherapy for high-risk bladder cancer that hasn't spread to the muscle. It aims to see which treatment best prevents the cancer from returning or getting worse.
For: Non-Muscle Invasive Bladder NeoplasmsUnited States · Argentina · Belgium - RecruitingPHASE3
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
This study looks at a new treatment called TAR-210 for a type of bladder cancer. It compares TAR-210 with standard chemotherapy to see which is better at keeping the cancer away.
For: Non-Muscle Invasive Bladder NeoplasmsUnited States · Argentina · Austria